GBS Inc. (NYSE:GBS – Get Free Report) shot up 7% on Friday . The stock traded as high as $1.29 and last traded at $1.23. 127,187 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 955,325 shares. The stock had previously closed at $1.15.
GBS Price Performance
The stock has a market cap of $18.91 million, a price-to-earnings ratio of -2.27 and a beta of 1.32. The company’s fifty day moving average price is $1.97 and its 200-day moving average price is $1.65.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Recommended Stories
- Five stocks we like better than GBS
- What is Short Interest? How to Use It
- Coca-Cola Stock Looks Refreshing After the Relief Rally
- What Are Some of the Best Large-Cap Stocks to Buy?
- CarMax Pulls Guidance: Shares Falling To Buyable Levels
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Bond ETFs for the Diversified Investor
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
